Revolution Medicines Inc (RVMD)
40.20
+1.01
(+2.58%)
USD |
NASDAQ |
May 03, 16:00
40.20
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Cash from Investing (Quarterly): -380.40M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -380.40M |
| September 30, 2023 | 77.35M |
| June 30, 2023 | -43.54M |
| March 31, 2023 | 3.996M |
| December 31, 2022 | -7.104M |
| September 30, 2022 | -123.44M |
| June 30, 2022 | 62.40M |
| March 31, 2022 | 44.02M |
| December 31, 2021 | 8.533M |
| September 30, 2021 | -30.18M |
| Date | Value |
|---|---|
| June 30, 2021 | -122.78M |
| March 31, 2021 | 2.309M |
| December 31, 2020 | 62.95M |
| September 30, 2020 | -100.97M |
| June 30, 2020 | -136.50M |
| March 31, 2020 | -59.72M |
| December 31, 2019 | 8.021M |
| September 30, 2019 | -59.80M |
| June 30, 2019 | -55.95M |
| March 31, 2019 | 5.761M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-380.40M
Minimum
Dec 2023
77.35M
Maximum
Sep 2023
-44.78M
Average
-30.18M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Cutera Inc | -2.599M |
| BioSig Technologies Inc | -0.004M |
| TRACON Pharmaceuticals Inc | 0.00 |
| Zentalis Pharmaceuticals Inc | -42.06M |
| Day One Biopharmaceuticals Inc | 30.38M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -120.56M |
| Cash from Financing (Quarterly) | 839.35M |
| Free Cash Flow | -358.30M |
| Free Cash Flow Per Share (Quarterly) | -0.8685 |
| Free Cash Flow to Equity (Quarterly) | -122.88M |
| Free Cash Flow to Firm (Quarterly) | -122.88M |
| Free Cash Flow Yield | -7.88% |